Search research articles
Contact Us
Filters
Showing results (31-40 of 72) with videos related to
Page
of 8
Sort By:
European Urology Oncology
|
March 12, 2026
An Open-label, Phase 1 Dose-finding Study of Single-agent IMU-935, a Novel RORγ/RORγt Inverse Agonist, in Patients with Progressive Metastatic Castration-resistant Prostate Cancer
Rafael Grochot, Christina Guo, Suzanne Carreira, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2015
Serial Next-Generation Sequencing of Circulating Cell-Free DNA Evaluating Tumor Clone Response To Molecularly Targeted Drug Administration
Jean Sebastien Frenel, Suzanne Carreira, Jane Goodall, et al.
European Urology
|
September 4, 2017
Novel Junction-specific and Quantifiable In Situ Detection of AR-V7 and its Clinical Correlates in Metastatic Castration-resistant Prostate Cancer
Yezi Zhu, Adam Sharp, Courtney M Anderson, et al.
Cell Reports
|
January 19, 2018
BRD4 Promotes DNA Repair and Mediates the Formation of TMPRSS2-ERG Gene Rearrangements in Prostate Cancer
Xiangyi Li, GuemHee Baek, Susmita G Ramanand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 23, 2020
Phase I Trial of First-in-Class ATR Inhibitor M6620 (VX-970) as Monotherapy or in Combination With Carboplatin in Patients With Advanced Solid Tumors
Timothy A Yap, Brent O'Carrigan, Marina S Penney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 29, 2020
Characterizing CDK12-Mutated Prostate Cancers
Pasquale Rescigno, Bora Gurel, Rita Pereira, et al.
European Urology Oncology
|
May 1, 2022
Immune Biomarkers in Metastatic Castration-resistant Prostate Cancer
María Dolores Fenor de la Maza, Khobe Chandran, Jan Rekowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 21, 2018
Targeting Bromodomain and Extra-Terminal (BET) Family Proteins in Castration-Resistant Prostate Cancer (CRPC)
Jonathan Welti, Adam Sharp, Wei Yuan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 10, 2024
Capivasertib in combination with enzalutamide for metastatic castration resistant prostate cancer after docetaxel and abiraterone: Results from the randomized phase II RE-AKT trial
Pasquale Rescigno, Nuria Porta, Laura Finneran, et al.
Cancer Discovery
|
May 28, 2021
Biomarkers Associating with PARP Inhibitor Benefit in Prostate Cancer in the TOPARP-B Trial
Suzanne Carreira, Nuria Porta, Sara Arce-Gallego, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 72) with videos related to
Sort By:
Page
of 8
European Urology Oncology
|
March 12, 2026
An Open-label, Phase 1 Dose-finding Study of Single-agent IMU-935, a Novel RORγ/RORγt Inverse Agonist, in Patients with Progressive Metastatic Castration-resistant Prostate Cancer
Rafael Grochot, Christina Guo, Suzanne Carreira, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2015
Serial Next-Generation Sequencing of Circulating Cell-Free DNA Evaluating Tumor Clone Response To Molecularly Targeted Drug Administration
Jean Sebastien Frenel, Suzanne Carreira, Jane Goodall, et al.
European Urology
|
September 4, 2017
Novel Junction-specific and Quantifiable In Situ Detection of AR-V7 and its Clinical Correlates in Metastatic Castration-resistant Prostate Cancer
Yezi Zhu, Adam Sharp, Courtney M Anderson, et al.
Cell Reports
|
January 19, 2018
BRD4 Promotes DNA Repair and Mediates the Formation of TMPRSS2-ERG Gene Rearrangements in Prostate Cancer
Xiangyi Li, GuemHee Baek, Susmita G Ramanand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 23, 2020
Phase I Trial of First-in-Class ATR Inhibitor M6620 (VX-970) as Monotherapy or in Combination With Carboplatin in Patients With Advanced Solid Tumors
Timothy A Yap, Brent O'Carrigan, Marina S Penney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 29, 2020
Characterizing CDK12-Mutated Prostate Cancers
Pasquale Rescigno, Bora Gurel, Rita Pereira, et al.
European Urology Oncology
|
May 1, 2022
Immune Biomarkers in Metastatic Castration-resistant Prostate Cancer
María Dolores Fenor de la Maza, Khobe Chandran, Jan Rekowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 21, 2018
Targeting Bromodomain and Extra-Terminal (BET) Family Proteins in Castration-Resistant Prostate Cancer (CRPC)
Jonathan Welti, Adam Sharp, Wei Yuan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 10, 2024
Capivasertib in combination with enzalutamide for metastatic castration resistant prostate cancer after docetaxel and abiraterone: Results from the randomized phase II RE-AKT trial
Pasquale Rescigno, Nuria Porta, Laura Finneran, et al.
Cancer Discovery
|
May 28, 2021
Biomarkers Associating with PARP Inhibitor Benefit in Prostate Cancer in the TOPARP-B Trial
Suzanne Carreira, Nuria Porta, Sara Arce-Gallego, et al.
Page
of 8